Mechanisms and Intervention Strategies for Frailty in Cirrhotic Patients

肝硬化是一种严重的肝脏疾病，其发展往往伴随患者出现衰弱现象，这不仅显著影响患者的生活质量，还与肝硬化的病程和预后密切相关。近年来，研究者们逐渐认识到衰弱的多因素机制，包括营养不良、炎症反应和代谢紊乱等，这些因素共同作用导致患者的体能下降及功能障碍。此外，针对肝硬化患者衰弱的有效干预策略日益受到重视。当前的干预措施主要包括营养支持、运动疗法和药物治疗等，旨在改善患者的身体状态和生活质量。尽管已有一些研究探讨了这些干预措施的效果，但对于不同患者群体的具体适应性仍需进一步评估。通过综合分析现有文献，本文旨在为临床实践提供参考，并促进未来研究的发展，以更好地理解肝硬化患者的衰弱机制及其干预策略。Liver cirrhosis is a severe liver disease, and its progression is often accompanied by frailty in patients, which significantly impacts their quality of life and is closely linked to disease course and prognosis. In recent years, researchers have increasingly recognized the multifactorial mechanisms of frailty, including malnutrition, inflammatory responses, and metabolic dysfunction. These factors collectively contribute to physical decline and functional impairment. Additionally, effective interventions for frailty in cirrhotic patients have gained attention. Current strategies focus on nutritional support, exercise therapy, and pharmacological treatments aimed at improving physical status and quality of life. While some studies have explored the efficacy of these interventions, their applicability across diverse patient populations requires further evaluation. Through a comprehensive review of existing literature, this paper aims to inform clinical practice and guide future research to better understand the mechanisms and intervention strategies for frailty in cirrhotic patients.